Timothy C. Barabe
Timothy C. Barabe's purchase track record
How the stock did after each of Timothy C. Barabe's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/4/2025 | RNAC | $206K | -0.3% | -5.1% | +10.6% |
| 8/12/2024 | RNAC | $95K | +55.8% | +45.8% | +13.5% |
| 5/9/2022 | RNAC | $39K | +223.0% | +103.4% | -4.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
RNAC Presents New Retreatment Data for Descartes-08 at MGFA Session. Cartesian Therapeutics shared additional retreatment data for its lead candidate Descartes-08 in patients with generalized myasthenia gravis. The results were presented at the MGFA scientific session of the 2026 AANEM annual meeting. This update adds to the company's clinical development information and may influence future regulatory discussions.
Transaction History
| HTFL | ▲ Buy | Option Exercise | 3,710 | $70K | 7/22/2026 | View on chart |
| HTFL | ▲ Buy | Option Exercise | 5,000 | $95K | 7/17/2026 | View on chart |
| HTFL | ▲ Buy | Option Exercise | 8,667 | $19K | 3/11/2026 | View on chart |
| HTFL | ▲ Buy | Option Exercise | 2,497 | $21K | 2/17/2026 | View on chart |
| RNAC | ▲ Buy | Grant | 2,600 | $0 | 1/2/2026 | View on chart |
| RNAC | ▲ Buy | Open Market | 30,000 | $206K | 12/4/2025 | View on chart |
| HTFL | ▼ Sell | Other | 131,578 | — | 8/11/2025 | View on chart |
| RNAC | ▲ Buy | Grant | 2,600 | $0 | 1/2/2025 | View on chart |
| RNAC | ▲ Buy | Open Market | 7,500 | $95K | 8/12/2024 | View on chart |
| RNAC | ▲ Buy | Grant | 178,000 | $0 | 1/2/2024 | View on chart |
| RNAC | ▲ Buy | Open Market | 50,000 | $39K | 5/9/2022 | View on chart |
| RNAC | ▲ Buy | Option Exercise | 10,000 | $21K | 1/14/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Heartflow featured in AI healthcare stock roundup
Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.
Heartflow featured in AI healthcare stock roundup. Heartflow was included in a recent Yahoo Finance article highlighting top AI healthcare stocks alongside Pfizer and another company. This mention places the firm in the conversation regarding artificial intelligence applications in the medical sector. The stock currently trades within its 52-week range, with analysts maintaining an average price target of $46.00.